Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunity.
about
DNA vaccines: a simple DNA sensing matter?Innate immunity to influenza virus: implications for future therapyVaccine platforms combining circumsporozoite protein and potent immune modulators, rEA or EAT-2, paradoxically result in opposing immune responsesManipulation of EAT-2 expression promotes induction of multiple beneficial regulatory and effector functions of the human innate immune system as a novel immunomodulatory strategyDNA vaccines: developing new strategies against cancer.A new domain in the Toll/IL-1R domain-containing adaptor inducing interferon-β factor protein amino terminus is important for tumor necrosis factor-α receptor-associated factor 3 association, protein stabilization and interferon signaling.Immunogenicity and efficacy of a plasmid DNA rabies vaccine incorporating Myd88 as a genetic adjuvant.Evidence for a DC-specific inhibitory mechanism that depends on MyD88 and SIGIRRLigand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunityReprogramming of murine macrophages through TLR2 confers viral resistance via TRAF3-mediated, enhanced interferon production.Technologies for enhanced efficacy of DNA vaccines.Innate Immune Signaling by, and Genetic Adjuvants for DNA VaccinationHarnessing DNA-induced immune responses for improving cancer vaccines.Demonstration of innate immune responses in the thyroid gland: potential to sense danger and a possible trigger for autoimmune reactions.Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells.The science of adjuvants.Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditisEpitope-based vaccine against influenza.Targeting intracellular signaling: a novel approach to vaccination.Intracellular detection and immune signaling pathways of DNA vaccines.Influenza vaccination in the elderly: seeking new correlates of protection and improved vaccines.Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases.Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity.Neoepitopes as cancer immunotherapy targets: key challenges and opportunities.Tapping the Potential of DNA Delivery with Electroporation for Cancer Immunotherapy.DAI (DLM-1/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity.CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8+ T Cell Responses.Host Immune Response to Influenza A Virus Infection.Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.Toll-Like Receptors Dysregulation after Influenza Virus Infection: Insights into Pathogenesis of Subsequent Bacterial Pneumonia
P2860
Q26859016-DEB5C587-8221-4ADD-908D-381270BFB001Q27489605-25E92491-4C0D-4F4F-975F-D44E4425D65BQ28740832-8A8E5D1B-7D66-4113-ABAE-6579812A6F10Q33749309-34DC1E21-3ACC-4A38-8129-C3267D877A98Q33756622-9911555A-0626-47A5-80F3-050560D001AEQ33759787-9D9552AD-A369-4F40-9190-9DDBEDAC19FBQ33850502-7FBBFF54-B13F-4AFC-83B9-B4D6FA587043Q33884220-64AC00A8-2393-4424-AAF2-54B9241C0AB0Q34153811-B9465DAC-6BA8-4171-B9E9-993981676757Q34819672-3ECD3742-A1B6-4BBA-8867-ADE368D67676Q35802958-2CA473FF-7CA7-4598-B1F7-2BAF6CB02B6FQ35826673-987346DB-202D-4CD1-9027-BC6FE920A989Q36694866-FDA415E0-E6BB-4367-B3E4-36B5F336C980Q36723438-755A52E8-6738-4ED2-988A-1A3EE9751F60Q36780146-7ADA1C74-5831-4A52-B47A-B688CDA91C87Q36968250-E37F507F-612A-4CDB-9911-B4E1789CC4D2Q36977614-4C239822-59A8-43AD-B8C6-AF96BA62286CQ37012089-1A6A75AB-8B86-4BE1-A4BB-E81DFA0F85B3Q37123459-835F3709-FBAE-4D32-A3F7-D3C75353B843Q37590333-4D847BA6-1FB9-49F4-99A1-F728F599233DQ37655007-D2DEAABA-5601-4FF0-BEC9-BD9872124358Q38342834-6F8D6982-1FAB-4BEB-B606-3D33AE870B4CQ38730774-52A85A05-AC46-40ED-B609-630CCA17D5C8Q39183391-199B179F-79FD-4503-ABF8-421BAB250D8EQ41435861-B92309C8-4773-4CE7-8615-05F1E0D566E4Q42208751-5101C6C9-DDFC-4CAB-89E8-CBF7FA779632Q48142387-AB831DD3-5B71-49E2-9D07-EC467355B96CQ52647758-36C394FB-ABAB-49A6-9261-E57341234E31Q55432126-10D2E943-489C-4234-8A59-7EF6C212F467Q58381054-E84B2147-8CBA-4221-A650-48A3F37D0324
P2860
Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunity.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Toll-like receptor adaptor mol ...... activation of innate immunity.
@ast
Toll-like receptor adaptor mol ...... activation of innate immunity.
@en
Toll-like receptor adaptor mol ...... activation of innate immunity.
@nl
type
label
Toll-like receptor adaptor mol ...... activation of innate immunity.
@ast
Toll-like receptor adaptor mol ...... activation of innate immunity.
@en
Toll-like receptor adaptor mol ...... activation of innate immunity.
@nl
prefLabel
Toll-like receptor adaptor mol ...... activation of innate immunity.
@ast
Toll-like receptor adaptor mol ...... activation of innate immunity.
@en
Toll-like receptor adaptor mol ...... activation of innate immunity.
@nl
P2093
P2860
P50
P356
P1433
P1476
Toll-like receptor adaptor mol ...... activation of innate immunity.
@en
P2093
Dennis M Klinman
Fumihiko Takeshita
Kenji Okuda
Kiyohiko Matsui
Kouji Kobiyama
Miyuki Tozuka
Norihisa Ishii
Shin Sasaki
Sukumar Saha
Tomoko Matsuda
P2860
P304
P356
10.1128/JVI.00121-06
P407
P577
2006-07-01T00:00:00Z